Congratulations to Karim Labib, who has just been awarded a Senior Investigator Award by the Wellcome Trust, which will amount to £1.8 million of funding over the next five years. These awards are intended to provide flexible support to the best researchers, in order to address some of the most important questions about health and disease.
Karim joined the MRC-PPU in October and his research group studies how the eukaryotic replisome allows cells to preserve their genome integrity and epigenetic information. This award from the Wellcome Trust will allow Karim's group to study the mechanisms of the eukaryotic replisome, complementing their MRC-funded work regarding the regulation of the replisome by ubiquitylation and phosphorylation.
Commenting on the award Karim said, "I am very grateful to the Wellcome Trust for their support, and this award will be extremely important for my lab. It makes perfect sense for us to study the mechanisms of the eukaryotic replisome in parallel with studying its regulation by post-translational modifications, and we now have the funding in place to do both. I am sure that the MRC-PPU and the College of Life Sciences will provide an ideal environment for our work."
Dario Alessi, Director of the MRC Unit added "I am thrilled that Karim has been able to secure prestigious Wellcome Trust funding to support his elegant research on understanding the molecular mechanism that controls the replication of DNA in Eukaryotes. This is an amazingly intricate and fundamental process. Karim's work has great potential to reveal innovative findings that that lead to critical insights into diseases such as cancer".
Karim joined the MRC-PPU in October and his research group studies how the eukaryotic replisome allows cells to preserve their genome integrity and epigenetic information. This award from the Wellcome Trust will allow Karim's group to study the mechanisms of the eukaryotic replisome, complementing their MRC-funded work regarding the regulation of the replisome by ubiquitylation and phosphorylation.
Commenting on the award Karim said, "I am very grateful to the Wellcome Trust for their support, and this award will be extremely important for my lab. It makes perfect sense for us to study the mechanisms of the eukaryotic replisome in parallel with studying its regulation by post-translational modifications, and we now have the funding in place to do both. I am sure that the MRC-PPU and the College of Life Sciences will provide an ideal environment for our work."
Dario Alessi, Director of the MRC Unit added "I am thrilled that Karim has been able to secure prestigious Wellcome Trust funding to support his elegant research on understanding the molecular mechanism that controls the replication of DNA in Eukaryotes. This is an amazingly intricate and fundamental process. Karim's work has great potential to reveal innovative findings that that lead to critical insights into diseases such as cancer".